Service Provider Life Cycle Management - Essential Steps to Achieving Quality and Compliance
More informationJoin the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationA report by European Federation of Pharmaceutical Industries and Associations
Open for comment now.
ICH M14 Guideline on General Principles on Plan, Design, and Analysis of Pharmacoepidemiological Studies that Utilize Real-World Data for Safety Assessment of Medicines.
The launch of a new version of the Clinical Trials Information System (CTIS) will allow earlier and more efficient access to information about clinical trials in the European Union (EU) for patients, healthcare professionals and other stakeholders. This is due to the revised transparency rules that become applicable today in Europe.
Article co-authored by EMA.
Article co-authored by EMA
13th June 2024
This guidance provides access to important Software Group outputs that might be of assistance.
The Accelerating Clinical Trials in the EU (ACT EU) initiative is today (10th June 2024) launching two advice pilots aimed at improving the quality of applications for clinical trials, the foundation for the development of safe and effective medicines in Europe.
CDRH’s Office of Science and Engineering Laboratories (OSEL) Information.